Editorial
doi: 10.1056/NEJMe048292.
The if and when of surgical debulking for ovarian carcinoma
- PMID: 15590959
- DOI: 10.1056/NEJMe048292
Item in Clipboard
Editorial
The if and when of surgical debulking for ovarian carcinoma
N Engl J Med.
.
No abstract available
Comment on
-
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer.N Engl J Med. 1995 Mar 9;332(10):629-34. doi: 10.1056/NEJM199503093321002. N Engl J Med. 1995. PMID: 7845426 Clinical Trial.
-
Secondary surgical cytoreduction for advanced ovarian carcinoma.N Engl J Med. 2004 Dec 9;351(24):2489-97. doi: 10.1056/NEJMoa041125. N Engl J Med. 2004. PMID: 15590951 Clinical Trial.
Similar articles
-
[Is there a standard therapy in advanced ovarian carcinoma?].Praxis (Bern 1994). 1999 Jan 21;88(4):123-5. Praxis (Bern 1994). 1999. PMID: 10067114 Review. German. No abstract available.
-
Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking.Ann Surg Oncol. 2006 Dec;13(12):1711-6. doi: 10.1245/s10434-006-9125-6. Epub 2006 Sep 29. Ann Surg Oncol. 2006. PMID: 17009146
-
Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer.Obstet Gynecol. 1989 Jan;73(1):61-5. Obstet Gynecol. 1989. PMID: 2462202
-
[Therapy of advanced ovarian carcinoma].Krankenpfl J. 2004;42(1-2):18-9. Krankenpfl J. 2004. PMID: 15116769 German. No abstract available.
-
[Prognostic factors of ovarian cancer].Gan To Kagaku Ryoho. 2006 Dec;33(13):2014-9. Gan To Kagaku Ryoho. 2006. PMID: 17197745 Review. Japanese.
Cited by
-
Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?Curr Urol Rep. 2005 May;6(3):183-9. doi: 10.1007/s11934-005-0006-5. Curr Urol Rep. 2005. PMID: 15869722 Review.
-
Diffusion-Weighted Magnetic Resonance Imaging in Ovarian Cancer: Exploiting Strengths and Understanding Limitations.J Clin Med. 2022 Mar 10;11(6):1524. doi: 10.3390/jcm11061524. J Clin Med. 2022. PMID: 35329850 Free PMC article. Review.
-
Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer.Ann Surg Oncol. 2023 Jun;30(6):3287-3299. doi: 10.1245/s10434-023-13242-8. Epub 2023 Feb 23. Ann Surg Oncol. 2023. PMID: 36820940
-
Visualization and quantification of intraperitoneal tumors by in vivo computed tomography using negative contrast enhancement strategy in a mouse model of ovarian cancer.Transl Oncol. 2009 May;2(2):96-106. doi: 10.1593/tlo.08199. Transl Oncol. 2009. PMID: 19412425 Free PMC article.
-
Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 Patients.Ann Surg Oncol. 2022 May;29(5):3322-3334. doi: 10.1245/s10434-021-11211-7. Epub 2022 Jan 7. Ann Surg Oncol. 2022. PMID: 34994906
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
